LVRNA-101

N/A

Report date: 2026/05/12 15:11:33

Base Information

Drug NameLVRNA-101
Drug Alias NameLVRNA101LVRNA-101
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccineCell and gene therapy > Gene therapy > mRNAVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHerpes Simplex Virus Type 2 Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesZhuhai Lifanda Biotechnology Co LtdChangchun Bcht Biotechnology Co
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesZhuhai Lifanda Biotechnology Co LtdChangchun Bcht Biotechnology Co
Inactive CompaniesN/A
Active IndicationsHerpes Simplex Virus Type 2 Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A